Financial Results — Winslow, Evans & Crocker

Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2022 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.PLEASE NOTE: This website contains hyperlinks (or “links”) to other websites that are not associated with this site. Such unassociated websites may contain links to other unassociated sites as well. These links are provided as a convenience to you and to assist you in your search for information. We make no endorsement, express or implied, about any of these linked sites, are not responsible for materials posted or activities that occur on such linked sites, and do not review (1) content or advertisements posted on or (2) activities occurring on these linked sites. If you decide to link to any unassociated website, it is at your own risk. Because we are not associated with these linked websites, you should direct any concerns or problems you might have with any such site to that site’s administrator or webmaster.” (these links can be found on the Market Action section and the Market News section)

Crispr Therapeutics Ag (NQ: CRSP )

Press Releases about Crispr Therapeutics Ag

Market Action

MARKET NEWS